1.
Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration.
Abrishami Majid, Zarei-Ghanavati Siamak, Soroush Dina, Rouhbakhsh Majid, Jaafari Mahmoud R, Malaekeh-Nikouei Bizhan
RetinaMay 2009132 citationsBasic Science
Nanoliposomal bevacizumab was studied for intravitreal use. It significantly prolonged drug presence in the vitreous, potentially reducing injection frequency and associated risks for patients.